Viemed sees ‘remarkable organic growth’
By HME News Staff
Updated 9:26 AM CDT, Thu August 8, 2024
LAFAYETTE, La. – Viemed Healthcare reported record revenue of $55 million for the second quarter of 2024, an increase of 27% year over year and 9% sequentially.
Net income was $1.5 million. Adjusted EBITDA was $12.8 million, an increase of 31% year over year.
“The remarkable organic growth of our complex respiratory services continues to validate our strategy at Viemed,” said Casey Hoyt, CEO. "Our second quarter results demonstrate the substantial demand for these essential services and confirm Viemed’s leading position in meeting the needs for complex respiratory care. The addressable market remains largely underserved, and our performance this quarter is a testament to our unwavering commitment to profitable growth by addressing the critical needs of an underserved market."
Viemed grew its ventilator patient count to a new company record of 10,905, an increase of 4.4% sequentially.
Comments